In breast cancer, common biomarkers are protein expression levels of estrogen receptor (ER), progesteron receptor (PR) as well as human epidermal growth factor (HER2), or mutations in the genes BRCA1 and BRCA2 [1–4]. This evidence concerns the gene ERBB2 and breast carcinoma.